Towards an Understanding of Barriers and Delays in the Diagnosis of Anal Cancer

Starting soon

Conditions studied: Squamous Cell Carcinoma of the Anal Canal, HPV-induced Cancer

In brief

This study examines care pathways in 300 patients with anal squamous cell carcinoma to identify barriers and delays in diagnosis, assess the impact of screening and access to care, and improve awareness, screening practices, and early diagnosis.

Key facts

Study ID

NCT07455942

Run by

Centre Hospitalier Intercommunal Creteil

People needed

300

Starts

2026-06-30

Expected to finish

2028-12-31

Last updated by the study team

2026-06-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female ≥ 18 years
• Histologically proven invasive or microinvasive squamous cell carcinoma of the anus
• Having read and understood the information letter provided, either:
• i. After disclosure of the diagnosis, or ii. At the latest 6 months after initiation of treatment (surgical excision, radiotherapy, or chemoradiotherapy)
• Affiliated with a social security system

You may not qualify if…

• Refusal to participate in the protocol
• Other histological types: lymphoma, adenocarcinoma, neuroendocrine tumor, etc.
• Time since treatment initiation greater than 6 months
• Protected persons (pregnant women, breastfeeding women, individuals under guardianship or curators, minors, persons deprived of liberty, or persons unable to express informed consent).

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.